785 related articles for article (PubMed ID: 34449302)
1. Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19-related Acute Respiratory Distress Syndrome.
Gerard L; Lecocq M; Bouzin C; Hoton D; Schmit G; Pereira JP; Montiel V; Plante-Bordeneuve T; Laterre PF; Pilette C
Am J Respir Crit Care Med; 2021 Nov; 204(9):1024-1034. PubMed ID: 34449302
[No Abstract] [Full Text] [Related]
2. Renin-Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome.
Hrenak J; Simko F
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126657
[TBL] [Abstract][Full Text] [Related]
3. [Lessons from SARS: a new potential therapy for acute respiratory distress syndrome (ARDS) with angiotensin converting enzyme 2 (ACE2)].
Imai Y; Kuba K; Penninger JM
Masui; 2008 Mar; 57(3):302-10. PubMed ID: 18340998
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract.
Ortiz ME; Thurman A; Pezzulo AA; Leidinger MR; Klesney-Tait JA; Karp PH; Tan P; Wohlford-Lenane C; McCray PB; Meyerholz DK
EBioMedicine; 2020 Oct; 60():102976. PubMed ID: 32971472
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme 2 protects from severe acute lung failure.
Imai Y; Kuba K; Rao S; Huan Y; Guo F; Guan B; Yang P; Sarao R; Wada T; Leong-Poi H; Crackower MA; Fukamizu A; Hui CC; Hein L; Uhlig S; Slutsky AS; Jiang C; Penninger JM
Nature; 2005 Jul; 436(7047):112-6. PubMed ID: 16001071
[TBL] [Abstract][Full Text] [Related]
6. Possible Therapeutic Interventions in COVID-19 Induced ARDS by Cotinine as an ACE-2 Promoter and AT-1R Blocker.
Sharma T; Mehan S
Infect Disord Drug Targets; 2021; 21(6):e170721189261. PubMed ID: 33342421
[TBL] [Abstract][Full Text] [Related]
7. In silico Nigellidine (N. sativa) bind to viral spike/active-sites of ACE1/2, AT1/2 to prevent COVID-19 induced vaso-tumult/vascular-damage/comorbidity.
Maiti S; Banerjee A; Kanwar M
Vascul Pharmacol; 2021 Jun; 138():106856. PubMed ID: 33746069
[TBL] [Abstract][Full Text] [Related]
8. [Role of ACE2 in COVID-19].
Imai Y
Nihon Yakurigaku Zasshi; 2022; 157(2):115-118. PubMed ID: 35228442
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme 2 (ACE2) expression increases with age in patients requiring mechanical ventilation.
Baker SA; Kwok S; Berry GJ; Montine TJ
PLoS One; 2021; 16(2):e0247060. PubMed ID: 33592054
[TBL] [Abstract][Full Text] [Related]
10. Renin-angiotensin system blockade on angiotensin-converting enzyme 2 and TMPRSS2 in human type II pneumocytes.
Silva MG; Falcoff NL; Corradi GR; Alfie J; Seguel RF; Tabaj GC; Iglesias LI; Nuñez M; Guman GR; Gironacci MM
Life Sci; 2022 Mar; 293():120324. PubMed ID: 35032553
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of ACE2 protein expression in rodent, non-human primate, and human respiratory tract at baseline and after injury: A conundrum for COVID-19 pathogenesis.
Soni S; Jiang Y; Tesfaigzi Y; Hornick JL; Çataltepe S
PLoS One; 2021; 16(2):e0247510. PubMed ID: 33626084
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin 1-7 Stimulates Proliferation of Lung Bronchoalveolar Progenitors-Implications for SARS-CoV-2 Infection.
Ciechanowicz AK; Lay WX; Prado Paulino J; Suchocki E; Leszczak S; Leszczak C; Kucia M
Cells; 2022 Jul; 11(13):. PubMed ID: 35805187
[TBL] [Abstract][Full Text] [Related]
13. Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists.
Steckelings UM; Sumners C
Clin Sci (Lond); 2020 Nov; 134(22):2987-3006. PubMed ID: 33210709
[TBL] [Abstract][Full Text] [Related]
14. Alveolar type II cells and pulmonary surfactant in COVID-19 era.
Calkovska A; Kolomaznik M; Calkovsky V
Physiol Res; 2021 Dec; 70(S2):S195-S208. PubMed ID: 34913352
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: A case study.
Karakaş Çelik S; Çakmak Genç G; Pişkin N; Açikgöz B; Altinsoy B; Kurucu İşsiz B; Dursun A
J Med Virol; 2021 Oct; 93(10):5947-5952. PubMed ID: 34170561
[TBL] [Abstract][Full Text] [Related]
16. ACE2: Its potential role and regulation in severe acute respiratory syndrome and COVID-19.
Rezaei M; Ziai SA; Fakhri S; Pouriran R
J Cell Physiol; 2021 Apr; 236(4):2430-2442. PubMed ID: 32901940
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of COVID-19 related gene expression in the COPD lung.
Watson A; Öberg L; Angermann B; Spalluto CM; Hühn M; Burke H; Cellura D; Freeman A; Muthas D; Etal D; Belfield G; Karlsson F; Nordström K; Ostridge K; Staples KJ; Wilkinson T;
Respir Res; 2021 May; 22(1):164. PubMed ID: 34051791
[TBL] [Abstract][Full Text] [Related]
18. The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice.
Imai Y; Kuba K; Penninger JM
Exp Physiol; 2008 May; 93(5):543-8. PubMed ID: 18448662
[TBL] [Abstract][Full Text] [Related]
19. The Impact of
Gintoni I; Adamopoulou M; Yapijakis C
In Vivo; 2022; 36(1):13-29. PubMed ID: 34972696
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia induces expression of angiotensin-converting enzyme II in alveolar epithelial cells: Implications for the pathogenesis of acute lung injury in COVID-19.
Sturrock A; Zimmerman E; Helms M; Liou TG; Paine R
Physiol Rep; 2021 May; 9(9):e14854. PubMed ID: 33991451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
